Introduction 27 28
Carotenoids are natural pigments produced in many fruits and vegetables, mushrooms 29 and algae and are responsible for colours ranging from red to yellow, although colorless 30 carotenoids are also found (e.g. phytoene, phytofluene). Carotenoids are lipids and most of 31 them can be described by the chemical formula C 40 H 56 O n , with n ranging from 0 to 6. They 32 are split into 2 classes: 33 -carotenes are non-oxygenated carotenoids (i.e. n=0). 34 -xanthophylls are oxygenated carotenoids (i.e. n>0). 35
To date, more than 750 different carotenoids have been identified but only about 40 are 36 consumed in significant amounts in the human diet, of which the most abundant are ß-37 carotene, lycopene, lutein, ß-cryptoxanthin, α-carotene, and zeaxanthin. Around 20 different 38 carotenoids have been identified in human blood (Khachik, Beecher, Goli, Lusby, & Smith, 39 1992) . The 6 most concentrated carotenoids are those found at the highest quantities in the 40 human diet. Astaxanthin and canthaxanthin are only found in the blood of subjects with an 41 elevated intake of foods rich in these carotenoids (i.e. some fish and seashells for the former, 42 some mushrooms for the latter). Carotenoids are potent antioxidant molecules with 43 antioxidant properties and their dietary intake and plasma levels have been associated with a 44 decreased risk of chronic diseases, including type-2 diabetes (Akbaraly, Fontbonne, Favier, & 45 Berr, 2008) , cardiovascular diseases (Y. Wang, Chun, & Song, 2013) and several types of 46 cancer (Tanaka, Shnimizu, & Moriwaki, 2012) . Some exhibit provitamin A properties, 47 M A N U S C R I P T
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7 enzyme for β-carotene (von Lintig, 2012) , lycopene has been suggested to be mostly cleaved 163 by BCO2 (Lindshield, Canene-Adams, & Erdman, 2007) . BCO2 has also been shown to be 164 involved in lutein metabolism (Amengual, et al., 2011) . While BCO1 is a cytosolic enzyme, 165 BCO2 localizes to the inner mitochondrial membrane which suggest the existence of a 166 compartmentalization between provitamin A carotenoid and xanthophyll metabolism 167 (Palczewski, Amengual, Hoppel, & von Lintig, 2014; Raghuvanshi, et al., 2015) . Most β-168 carotene conversion (>70%) has been shown to take place in the intestine (Tang, Qin, 169 Dolnikowski, & Russell, 2003; Z. Wang, Yin, Zhao, Russell, & Tang, 2004) . Additionally, 170 carotenoid isomerisation can occur in the enterocyte and it has actually been reported that this 171 was the key site for lycopene isomerisation during absorption in human subjects, since no 172 isomerisation was observed in the gastro-intestinal lumen (Richelle, et al., 2010) . 173 It is widely accepted that carotenoids follow the fate of other newly absorbed lipid 178 molecules (fatty acids, monoglycerides, cholesterol…) and that they are incorporated with 179 them in chylomicrons in the Golgi apparatus before secretion in the lymph (apolipoprotein B-180 dependent route). Nevertheless, another secretion pathway could exist. Indeed, since some 181 carotenoids are found in HDL and since the small intestine synthesizes HDL, which can 182 transport other newly absorbed lipid molecules, namely cholesterol and vitamin E, it can be 183 hypothesized that a fraction of carotenoids is secreted into the lymph in HDL (apolipoprotein 184 A1-dependent route) involving the transporter ATP binding cassette AI (ABCA1). This has 185 been confirmed in vitro and in a hamster model for lutein and zeaxanthin where up-and 186 down-regulation of ABCA1 expression, via activation of the liver X receptor and statin 187 treatment respectively, led to respectively increased and decreased HDL-lutein and -188 zeaxanthin concentrations (Niesor, et al., 2014) . The metabolic pathways of carotenoid 189 transport through the enterocyte are summarized in Figure 1 . 190 191
Blood transport of carotenoids 192 193
Since some carotenoids (notably xanthophylls) are principally localized at the surface 194 of chylomicrons (Borel, et al., 1996) , a fraction of carotenoids is probably transferred to other 195 classes of lipoproteins and/or to some tissues during intravascular metabolism ofM A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 8 chylomicrons (Tyssandier, Choubert, Grolier, & Borel, 2002) . Carotenoids that reach the liver 197 via chylomicrons are stored in this organ, or eliminated in the bile, or re-secreted into VLDL 198 to be distributed to peripheral tissues. It can be hypothesized that a fraction of carotenoids (notably xanthophylls for the above-mentioned reasons) is exchanged with some 200 other classes of lipoproteins during the metabolism of these lipoproteins. A part of VLDL-201 carotenoids, notably carotenes which are preferentially located in the hydrophobic core of 202 these triglyceride-rich lipoproteins (Borel, et al., 1996) , is found in LDL, which originate 203 from VLDL metabolism. LDL-carotenoids are probably taken up by tissues together with 204 LDL. It can be hypothesized that a fraction of preferentially xanthophylls, 205 is exchanged with other classes of lipoproteins. The origin of HDL-carotenoids is not known 206 but they can come from peripheral tissues, which would be somehow a reverse metabolism of 207 carotenoids, or from other lipoprotein classes (through the exchanges between lipoproteins 208 described above), or from the intestine (see section 3.4), or from a combination of some of 209 these factors. Following these exchanges, xanthophylls are transported mostly in HDL while 210 carotenes are transported mostly in LDL (Thomas & Harrison, 2016) . Carotenoids are found in numerous tissues but at very different concentrations 216 (Schmitz, Poor, Wellman, & Erdman, 1991) . The adipose tissue and the liver respectively 217 contain 80 and 10% of total carotenoids in the body, although the highest concentrations are 218 not found in these organs. Very little is known on the mechanisms governing carotenoid tissue 219 distribution. It is accepted that these lipophilic pigments follow the fate of lipids. It is thus 220 hypothesized that carotenoids incorporated into LDL are taken up by tissues together with 221 these lipoproteins (see chapter 4). Moreover, since some putative membrane transporters of 222 carotenoids (i.e. SR-BI, CD36ABCA1…) are found at the cell surface of some tissues 223 (Moussa, et al., 2011; Rigotti, Miettinen, & Krieger, 2003) , it is possible that the cell 224 internalisation of some carotenoids present at the surface of lipoproteins (xanthophylls 225 notably) is facilitated by these transporters. It is also possible that some membrane proteins 226 are involved in the efflux of carotenoids from peripheral tissues to the blood circulation. 227
Carotenoid analysis in the eyes of dead bodies have shown that, although around 40 228 carotenoids are consumed by humans, only very few are found in this organ, namely lutein, 229 zeaxanthin, meso-zeaxanthin, and to a lesser extent lycopene and ß-carotene (Bernstein, et al., lens and retina, these carotenoids are sometimes considered as the "carotenoids of vision". 232
The macular pigment density, i.e. the concentration of carotenoids present in the macula, is 233 partly correlated to lutein+zeaxanthin and β-carotene consumption and serum lutein and 234 zeaxanthin concentration (Curran-Celentano, et al., 2001) , and dietary intakes of lutein 235 increase macular pigment density (Landrum, et al., 1997) . Regarding meso-zeaxanthin 236 (3R,3'S-zeaxanthin), it comes from lutein metabolism, as it has been shown when monkeys 237 were fed either lutein or zeaxanthin (Johnson, Neuringer, Russell, Schalch, & Snodderly, 238 2005) . These studies in monkeys have also shown that lutein and zeaxanthin in the macula 239 cannot interconvert, which suggests it is necessary to have a dietary intake of both carotenoids 240 to maintain a normal macular pigment composition. Recently, a mechanism has been 241 proposed to explain the selective uptake of zeaxanthin and lutein in the retina, where 242 zeaxanthin transport from HDL is facilitated by SR-BI while lutein transport from LDL is 243 probably facilitated by the LDL receptor (Thomas & Harrison, 2016) . 244
Xanthophylls, and more precisely esterified lutein, have been found in the skin 245 (Wingerath, Sies, & Stahl, 1998 ), but it is not known if these esters are formed in this tissue, 246 through esterification of free lutein, or if they are absorbed as such and then transported to the 247 skin (see section 3.5). Lycopene and ß-carotene are the main carotenoids found in the prostate 248 (Clinton, et al., 1996) with concentrations ranging from 0 to 2.6 nmol/g for lycopene and from 249 0.09 to 1.7 nmol/g for ß-carotene. The presence of significant amounts of lycopene in this 250 organ support the results of epidemiological studies which suggest this carotenoid plays a 251 preventive role against the development of prostate cancer (Jian, Du, Lee, & Binns, 2005; 252 Wertz, Siler, & Goralczyk, 2004) . 253
Lutein and zeaxanthin have been found at relatively high concentrations in the human 254 brains where they have been suggested to have a beneficial role on cognitive function 255 (Johnson, 2012) . proposed to list all factors susceptible to affect carotenoid bioavailability (West & 266 Castenmiller, 1998) 
Species of carotenoids and molecular Linkage 287 288
The study of the effect of carotenoid species on their bioavailability is not 289 straightforward due the variability of the matrices in which they are incorporated (see section 290 6.3). To differentiate between these effects, it is necessary to measure the bioavailability of 291 pure carotenoids. This was done in a study carried out in rats which showed that carotenoid 292 bioavailability was inversely correlated with their hydrophobicity (i.e. the bioavailability of 293 carotenoids was as follows: astaxanthin>lutein>β-carotene>lycopene), which was mainly due 294 to differences in their bioaccessibility according to the authors (Sy, et al., 2012) . 295
Due to their many conjugated double bonds, each carotenoid can theoretically form 296 many geometrical isomers. For example, ß-carotene, with 9 double bonds in its polyene chain, 297 can form 272 isomers while lycopene can theoretically form 1056 geometrical isomers. 298 M A N U S C R I P T
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However, the steric hindrance of some configurations limits the number of cis isomers to a 299 few dozens. As a consequence, carotenoids are found in the human diet under 4 main 300 chemical forms: all-trans carotenoids, all-trans esterified carotenoids (Weller & Breithaupt, 301 2003) , cis carotenoids and cis esterified carotenoids. However, most carotenoids are usually 302 present as all-trans non-esterified carotenoids. The fraction of cis isomers present in our diet 303 is usually produced by technological treatments, in particular elevated temperatures 304 (Milanowska & Gruszecki, 2005; Rodriguez-Amaya, 1999; Updike & Schwartz, 2003) . A 305 "trans to cis" conversion in the acidic environment of the stomach has also been proposed 306 (Mortensen & Skibsted, 2000) , although it has not been observed in vivo (Richelle, et al., 307 2010; Tyssandier, et al., 2003) . However, Richelle et al. reported lycopene conversion to 308 occur within the enterocyte (Richelle, et al., 2010) . Cis isomers have different physico-309 chemical properties compared to corresponding all-trans isomers: they are no longer linear, 310 rigid molecules, which affect their capacity to solubilize into mixed micelles (Milanowska, 311 Polit, Wasylewski, & Gruszecki, 2003) . Their tendency to crystallise or aggregate is also 312 diminished (Britton, 1995) . As a consequence, it has been hypothesized that they have 313 different absorption efficiency. This has been investigated in several studies. Cis lycopene 314 isomers have been shown to display a higher bioavailability than the all-trans isomer 315 (Boileau, Boileau, & Erdman, 2002; Cooperstone, et al., 2015) , which would be due to a 316 higher solubility in mixed micelles. Cis ß-carotene isomers also display a higher solubility in 317 mixed micelles compared to all-trans ß-carotene (G. Levin & Mokady, 1995; Tyssandier, et 318 al., 2003) but surprisingly, they have a lower absorption efficiency (Ben-Amotz & Levy, 319 1996) . This apparent discrepancy could originate from the fact that cis ß-carotene isomers are 320 isomerised to all-trans ß-carotene in enterocytes (You, Parker, Goodman, Swanson, & Corso, 321 1996) , which leads to an underestimation of their absorption efficiency. Of note, whether all-322 trans ß-carotene enterocyte uptake is favoured remains controversial since a study with 323 synthetic mixed micelles has shown a greater uptake of all-trans ß-carotene vs cis ß-carotene 324 (During, Hussain, Morel, & Harrison, 2002) while another study did not observe any 325 difference using micelles produced following in vitro digestions (Ferruzzi, Lumpkin, 326 Schwartz, & Failla, 2006) . 327
As mentioned earlier, carotenoids are found in the diet either as free carotenoids (for 328 carotenes and xanthophylls) or esterified (for xanthophylls only). However, it is estimated that 329 in the usual French diet, more than 90% carotenoids are consumed as free. Since, by analogy 330 with what is observed with cholesterol and retinyl esters, carotenoids are supposed to be 331 absorbed only as free, the absorption efficiency of esterified carotenoids was thought to be 332
inexistent. However, it was shown in a clinical study that lutein esters had a bioavailability 333 equivalent to that of free lutein (Bowen, Herbst-Espinosa, Hussain, & Stacewicz-Sapuntzakis, 334 2002) , and the bioavailability of zeaxanthin dipalmitate was even greater than that of free 335 zeaxanthin in another clinical study (Breithaupt, Weller, Wolters, & Hahn, 2004) . This has 336 also been observed with another xanthophyll ester, namely esterified ß-cryptoxanthin 337 (Breithaupt, Weller, Wolters, & Hahn, 2003) . These results suggest that the hydrolysis of 338 xanthophyll esters in the intestinal lumen is a highly efficient process. It can also be 339 hypothesized that the facilitated transport of xanthophyll esters are more soluble in mixed 340 micelles than free xanthophylls or that their facilitated transport by membrane proteins is 341 more efficient than that of free xanthophylls. 342 343
Amount of carotenoids consumed in a meal 344 345
The absorption efficiency of carotenoids is thought to remain constant to amounts up 346 to 20-30 mg and then decrease for greater amounts due to several factors: limited capacity of 347 mixed micelles to solubilise carotenoids, saturation of membrane proteins involved in their 348 intestinal transport (see section 3.1), saturation of the solubilisation capacity of the 349 intracellular compartment and/or chylomicrons (Stahl, et al., 2002) . This saturation of the 350 absorptive capacity has been reported for lycopene (Diwadkar-Navsariwala, et al., 2003) . This factor is considered to be the key factor governing carotenoid bioavailability 355 because, to be absorbed, carotenoids first need to be extracted from their food matrix and to 356 be incorporated into mixed micelles in the upper part of the digestive tract. In plants, 357 carotenoids are found in different structures: they can be present in chloroplasts in the 358 photosynthetic system (in particular in the leaves of green plants) or in chromoplasts, 359 dissolved in lipid droplets (in some fruits), or in a semi-crystal state associated to membranes 360 (in carrots and tomatoes for example) (Vishnevetsky, Ovadis, & Vainstein, 1999) . These 361 differences in their localization and physical form are supposed to significantly affect their 362 extraction efficiency and hence their bioaccessibility (i.e. % found in micelles) (Reboul, 363 Richelle, et al., 2006; Xia, McClements, & Xiao, 2015) and bioavailability (Schweiggert & 364 Carle, 2015) . To illustrate this point, lutein and β-carotene were more bioavailable from 365 broccolis (a flower) or green peas (a seed) than from spinach (where carotenoids are found inM A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 13 chloroplasts) (van het Hof, Tijburg, Pietrzik, & Weststrate, 1999) . Likewise, the 367 bioavailability of carotenoids present in food not from plant origin is usually higher than that 368 of carotenoids present in food from plant origin, probably because they are then not trapped 369 by plant membranes and dietary fibres. For example, lutein from eggs was more bioavailable 370 than lutein from spinach and supplements (Chung, Rasmussen, & Johnson, 2004) . 371
Technological treatments and cooking usually improve carotenoid bioavailability and 372 can thus compensate, at least partly, for their degradation. This is explained by the fact that 373 these treatments alter plant cell walls and lead to a higher carotenoid extraction. Several 374 studies have thus shown a higher carotenoid bioaccessibility following thermal or non-thermal 375 processing (Buniowska, Carbonell-Capella, Frigola, & Esteve, 2017; Gupta, Kopec, 376 Schwartz, & Balasubramaniam, 2011; Reboul, Richelle, et al., 2006) . These differences in 377 bioaccessibility usually translate to differences in bioavailability. For example, lutein 378 bioavailability from spinach is higher when the spinach matrix is altered (through chopping in 379 this case) (van het Hof, et al., 1999) and it is higher in vegetable juices compared to raw or 380 cooked vegetables (McEligot, et al., 1999) . Likewise, the bioavailability of β-cryptoxanthin 381 has been shown to be higher in pasteurized orange juice compared to fresh oranges (Aschoff, 382 et al., 2015) . absorption. Lipids increase the bioavailability of both free (Unlu, Bohn, Clinton, & Schwartz, 390 2005) and esterified lutein (Roodenburg, Leenen, Hof, Weststrate, & Tijburg, 2000) . When 391 raw vegetables were consumed together with cooked whole eggs (each egg provided 5 g 392 lipids), lutein, zeaxanthin, α-carotene, β-carotene, and lycopene bioavailability increased 3-8 393 fold (Kim, Gordon, Ferruzzi, & Campbell, 2015) . Similarly, consumption of avocado together 394 with tomatoes or raw carrots has been shown to increase the bioavailability of β-carotene and 395 its conversion efficiency to vitamin A (Kopec, et al., 2014 -the species of fatty acids from triglycerides (Borel, et al., 1998; Gleize, et al., 2013; 408 Schaeffer & Hamilton, 1990) . For example, olive and coconut oils have been shown to 409 increase similarly the intestinal absorption of lutein in mice when compared to groundnut, 410 soybean, sunflower, rice bran, corn, palm and fish oil (Nidhi, Ramaprasad, & Baskaran, 411 2014) . In humans, canola oil, which is rich in monounsaturated fatty acids, was shown to 412 trend to promote higher lutein and α-carotene bioavailability compared to butter, which is 413 rich in saturated fatty acids (Goltz, Campbell, Chitchumroonchokchai, Failla, & Ferruzzi, 414 2012) . 415 -the amount of amphiphilic lipids (mostly phospholipids). 416 -the species of amphiphilic lipids. It is supposed that, before its hydrolysis to 417 lysophosphatidylcholine, phosphatidylcholine could affect carotenoid absorption by 418 decreasing lipolysis speed and hence micelle formation speed. Phosphatidylcholine inhibits 419 lutein absorption while lysophosphatidylcholine has the opposite effect (Sugawara, et al., 420 2001) . 421 -the extent of lipid emulsification. For example, the use an excipient emulsion with 422 decreasing droplet size has been shown to increase the bioaccessibility of α-and β-carotene 423 from carrot juice in vitro and an emulsion with small droplet size 424 increased enterocyte uptake of β-carotene in Caco-2 cells (Lu, et al., 2016 (Eastwood & Mowbray, 1976) . 430 -by inhibiting pancreatic lipase (W. E. Hansen, 1987) , which would decrease carotenoid 431 extraction from lipid droplets (Tyssandier, et al., 2001) .
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-by increasing the viscosity of the intestinal content (Gallaher, Hassel, Lee, & Gallaher, 433 1993) which would impair the diffusion of carotenoid-rich micelles towards the brush 434
border. 435
This was confirmed in a study showing that a diet rich in pectin, guar gum, alginate cellulose 436 or wheat bran (0.15 g/kg body weight) decreased lutein bioavailability (Riedl, Linseisen, 437 Hoffmann, & Wolfram, 1999 Olestra, a saccharose polyester used as a lipid substitute, has been shown to decrease the 446 absorption of β-carotene and lycopene (Weststrate & Hof, 1995) . Similarly, phytosterols, 447 which are used to decrease cholesterol absorption efficiency, also decrease the absorption of 448 some carotenoids (α-and ß-carotene and lycopene) (Clifton, et al., 2004; Richelle, et al., 449 2004) although no effect was observed on β-cryptoxanthin bioavailability following the 450 consumption of a milk-based fruit drink with or without plant free sterols for 28 days 451 and subsequent uptake by enterocytes (During, et al., 2002; Tyssandier, Cardinault, et al., 460 2002; Tyssandier, et al., 2001; van den Berg, 1999) . However, the effect of such competition 461 on long term carotenoid status is not yet certain (Tyssandier, Cardinault, et al., 2002) . On the 462 other hand, microconstituants such as vitamin C, polyphenols and vitamin E are thought to 463 protect carotenoids against oxidative degradation in the gastro-intestinal tract, and thus 464 increase their absorption efficiency. The results are here conflicting since vitamin C has been 465 suggested to increase lutein absorption (Tanumihardjo, Li, & Dosti, 2005) , but results fromM A N U S C R I P T
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our lab are in disagreement: the postprandial lutein response to a lutein-rich meal containing a 467 mixture of antioxidants, including vitamin C, was not different compared to a lutein-rich meal 468 only . Additionally, vitamin C had no effect on lutein uptake by Caco neoxanthin, lycopene and β-carotene, with calcium having the most pronounced effect (100% 475 reduction when added at 1000 mg/l) (Corte-Real, et al., 2016) . In agreement with these 476 results, the bioavailability of lycopene in humans has recently been shown to be significantly 477 diminished when calcium was added at a nutritional dose to a test meal (83% reduction) 478 . These results call for a thorough assessment of the effects of calcium, or 479 other divalent minerals, on the bioavailability of carotenoids. 480 481
Vitamin A (Nutrient) status of the host 482 483
The variability in β-carotene absorption has been associated with host vitamin A 484 status: following its activation by retinoic acid, the intestinal transcription factor Intestine 485 Specific Homeobox (ISX) has been shown to function as a repressor of SCARBI and BCO1 486 expression (Lobo, et al., 2010) . This mechanism is thought to serve as a negative feedback 487 loop regulating retinol status through modulation of provitamin A carotenoid absorption and 488 cleavage efficiencies. Moreover, the presence of a SNP in the ISX binding site in the BCO1 489 promoter was associated with decreased conversion rates by 50% and increased fasting blood 490 levels of β-carotene (Lobo, et al., 2013) . Since lutein and lycopene are also absorbed via SR-491 BI, it can be hypothesized that the host vitamin A status also has an effect on the absorption of 492 these carotenoids (Widjaja-Adhi, Lobo, Golczak, & Von Lintig, 2015) . 493 494
Genetic factors 495 496
The involvement of several proteins in the intestinal absorption of carotenoids (apical 497 uptake) suggests that variations in the genes encoding these proteins could modulate 498 carotenoid absorption efficiency. This has been confirmed in an association study by Borel et 499 al. (2007) where the influence of candidate SNPs of genes involved in lipid metabolism on 500 M A N U S C R I P T
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the fasting blood concentration of several carotenoids was investigated. More specifically, 501
SNPs in SCARB1 were associated with β-carotene but not with lycopene concentrations. 502
These SNPs explained differences in β-carotene plasma concentrations by up to 50%. Several 503 additional SNPs have meanwhile been identified (Borel, 2012) , including several in BCO1 in 504 genome-wide association studies (Ferrucci, et al., 2009; Wood, et al., 2013) . Three recent 505 studies have reported associations of combinations of SNPs involved in interindividual 506 variability of the bioavailability of lutein (Borel, et al., 2014) , lycopene (Borel, 507 Desmarchelier, Nowicki, & Bott, 2015b) and β-carotene (Borel, Desmarchelier, Nowicki, & 508 Bott, 2015a), employing a candidate gene approach in postprandial studies. In these studies, 509 plasma chylomicron carotenoids, representing newly absorbed carotenoids, were measured in 510 healthy male adults. These combinations were associated with 73, 72 and 69% of the 511 interindividual variability of the bioavailability of lutein, lycopene and β-carotene, 512 respectively. While some SNPs were located in genes expressed in other tissues or were 513 closely involved in plasma chylomicron metabolism, others were involved with carotenoid 514 transport or metabolism at the enterocyte level. These included ABCA1, ABCG5, BCO1, 515 CD36, ELOVL2 (ELOVL fatty acid elongase 2), and ISX. Interestingly, one SNP in ELOVL2 516 (rs9468304) was very strongly associated with all three phenotypes, possibly due to the 517 inhibitory effect of eicosapentaenoic acid, which is further elongated to docosapentaenoic 518 acid and docosahexaenoic acid by ELOVL2, on carotenoid absorption, as has been shown 519 with β-carotene (Mashurabad, et al., 2016) . 520 521
Host-related factors 522 523
Several studies have shown that some host-related factors could modulate carotenoid 524 absorption (see (Bohn, et al., 2017) for a recent review). 525 526 6.7.1 Gender 527 528 Females usually exhibit higher blood carotenoid concentrations than men (Brady, 529 Maresperlman, Bowen, & Stacewiczsapuntzakis, 1996) . This can be due to several reasons: 530 differences in fruit and vegetable consumption (which are the main sources of carotenoids), 531 differences in carotenoid absorption efficiency, differences in total blood volume (which is 532 lower in women and hence will lead to a higher blood carotenoid concentration following the 533 consumption of a similar amount of carotenoids) and differences in metabolism. The secondM A N U S C R I P T
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hypothesis was ruled out by a study in which no differences in ß-carotene bioavailability 535 (including the corresponding appearance of retinyl palmitate in the chylomicron fraction) was 536 observed between men and women following the consumption of 40 mg encapsulated ß-537 carotene with a standard meal (O'Neill & Thurnham, 1998 The observed deterioration of gastro-intestinal tract functions concomitant with aging 542 (Ikuma, Hanai, Kaneko, Hayashi, & Hoshi, 1996; Vellas, Balas, & Albarede, 1991) could 543 affect carotenoid absorption efficiency. Although this has been shown in the case of lycopene, 544 no differences in α-, ß-carotene and lutein absorption efficiency were observed between 545 young and older subjects (Cardinault, et al., 2003) . 546 547 6.7.3 Diseases 548 549 Any disease that alter the intestinal mucosal surface area can potentially alter 550 carotenoid absorption efficiency. As most studies do not directly measure carotenoid 551 bioavailability but rather look at carotenoid status (usually their fasting blood concentration), 552 it is of paramount importance to control for carotenoid dietary intake since indirect effects of 553 the disease on carotenoid absorption can also occur (through dietary adaptations, e.g. high 554 fibre or low fat diet). Patients with cystic fibrosis have been shown to have lower plasma 555 lutein and zeaxanthin concentrations compared to healthy subjects (Homnick, Cox, DeLoof, 556 & Ringer, 1993; Schupp, et al., 2004) . Several studies have shown that patients with Crohn's 557 disease also exhibited lower fasting blood carotenoid concentrations (Drai, et al., 2009; 558 Geerling, Badart-Smook, Stockbrugger, & Brummer, 1998; Genser, Kang, Vogelsang, & 559 Elmadfa, 1999) . In another study, subjects with Celiac disease and Crohn's disease showed 560 37% decreased levels of macular carotenoids compared to controls despite normal serum 561 carotenoids levels (Ward, Zhao, & Bernstein, 2008) . 562
Surgical removal of parts of the gastro-intestinal tract can also reduce carotenoid 563 absorption efficiency. Patients undergoing bariatric surgery (Roux-en-Y gastric bypass and 564 biliopancreatic diversion) have been reported to display lower blood carotenoid 565 concentrations despite apparently normal fruit and vegetable consumption Lorencio, Simal-Anton, Blanco-Navarro, Gonzalez-Dominguez, & Perez-Sacristan, 2011) . 567
Short bowel syndrome, usually due to large resections of the small intestine to treat 568 M A N U S C R I P T
19 pathologies such as Crohn's disease or gastrointestinal tumours, have also been associated 569 with carotenoid malabsorption: Edes et al. (1991) reported undetectable β-carotene blood 570 levels following supplementation, despite adequate fat absorption, in a patient with extensive 571 small intestinal resection (serum vitamin A levels appeared normal) while in another study, no 572 increase in blood carotenoid concentration were reported in patients given a 12-week-long 573 supplementation with β-carotene, lutein and lycopene, most likely due to low fat absorption in 574 these patients (about 30% vs >95% in healthy subjects) (Luo, et al., 2009) . 575 576 Intestinal parasites and gastro-intestinal tract dysbiosis (e.g. bacterial overgrowth) can 577 also damage mucosal cells and result in increased permeability and decreased absorption of 578 nutrients. Indonesian children infected with intestinal helminths exhibited greater increase in 579 serum retinol concentrations when they were dewormed following consumption of red sweet 580 potato (Jalal, Nesheim, Agus, Sanjur, & Habicht, 1998) , possibly due to improved fat 581 absorption. 582 583
Mathematical Interactions 584 585
Several of the above-mentioned factors can interact together, with an additive, 586 synergistic or antagonist effect. Albeit there are no dedicated studies, it can be hypothesized 587 that, although there is no effect of lutein esterification on its bioavailability in healthy subjects 588 (see section 6.1), it is likely that this effect will be significantly higher in patients with lipid 589 malabsorption, i.e. with low pancreatic secretion and thus esterases which hydrolyse lutein 590 esters. 591 592
Conclusions 593 594
The absorption mechanisms of carotenoids are complex. This review underlines the 595 vast amount of work still needed to improve our knowledge of carotenoid absorption and its 596 modulating factors ("SLAMENGHI") (see (Bohn, et al., 2015) for a recent review). Indeed, 597 several key points still need to be investigated: 598 • Carotenoid bioavailability displays a relatively high variability.
• The absorption mechanisms of carotenoids are complex and involve numerous steps.
• Carotenoid bioavailability is affected by dietary factors (e.g. food matrix, fat).
• It is also affected by host-related factors (e.g. diseases, genetic variations).
• A better knowledge thereof could lead to more personalised dietary recommendations.
